Cream for eczema in children – test of gentle skin care
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be between 3 months and 12 years old.
- Must have had at least 3 eczema flare-ups in the last 6 months.
- Must currently have a flare-up that needs prescription corticosteroid cream.
- Must have a SCORAD score between 15 and 40 (moderate eczema).
- Must have Polish citizenship.
- Must have a parent or guardian who agrees to the study and follow its rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new cream (FilmoCream) plus steroid ointment works better than steroid ointment alone for mild-to-moderate eczema. You must have two separate eczema patches that need steroid treatment.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This trial compares two moisturizers for people with eczema (moderate rash) and healthy volunteers. It looks at how well they work and how the skin tolerates them after using a steroid cream.
This study tests a probiotic ointment for children aged 6 months to 15 years with mild-to-moderate eczema (measured by a skin score of 15–50). It aims to see if the cream is safe and helps improve their skin.
This trial tests an investigational cream called GX-03 for adults with moderate to severe eczema (atopic dermatitis). Participants apply the cream to affected skin daily, and the study compares it to a placebo cream to see if it improves symptoms safely.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.